A Study of the Effect of Plasmaexchange in Patients With Acute Liver Failure
European Multicenter Plasma Exchange Trial (Empet): A Controlled, Open, Randomised, Multicenter Study In Patients With Acute Liver Failure
Sponsor: Rigshospitalet, Denmark
This NA trial investigates Acute Liver Failure and is currently completed. Rigshospitalet, Denmark leads this study, which shows 5 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jun 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Rigshospitalet, Denmark
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Copenhagen, Denmark
- • Helsinki, Finland
- • London, United Kingdom